查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1985968

美國外骨骼市場規模、佔有率和趨勢分析報告：按移動性、技術、目標部位、應用、地區和細分市場分類，預測期為2026-2033年

U.S. Exoskeleton Market Size, Share & Trends Analysis Report By Mobility, By Technology, By Extremity, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國外骨骼市場概述

據估計，2025 年美國外骨骼市場價值為 2.3418 億美元，預計到 2033 年將達到 6.4025 億美元，2026 年至 2033 年的複合年成長率為 13.09%。

美國外骨骼產業的主要成長動力來自老年人口的快速成長、汽車、軍事、國防和建築等產業對醫療設備日益普及以及中風的發病率的上升。

創傷性脊髓損傷（SCI）發病率的上升預計將推動美國市場的需求成長。例如，美國脊髓協會在2025年9月報告稱，美國有25萬至39萬人患有脊髓損傷，每年新增病例約1.8萬例。主要病因是車禍和跌倒。該協會還強調了常見的繼發性併發症，包括憂鬱症、慢性疼痛、痙攣、壓瘡以及腸道、膀胱和呼吸問題。

外骨骼解決方案的應用日益普及，尤其是在幫助脊髓損傷患者恢復行動能力和進行復健方面。在美國，穿戴式機器人領域的持續創新正推動製造商推出具有更強個人化和數位化整合能力的下一代系統。例如，Lifeward Ltd. 於 2025 年宣布其最新個人外骨骼「ReWalk 7」在全美範圍內上市。這款新系統融合了雲端連接、自適應軟體和步行速度調節等先進功能，為脊髓損傷使用者提供更細緻入微的步行體驗。此次發布體現了該公司致力於提升美國市場外骨骼輔助步行解決方案的用戶自主性、臨床療效和實際應用價值的策略重點。

「經過數年的研發，ReWalk 7 應運而生，它融合了先進的技術創新以及來自臨床醫生和患者的反饋，旨在進一步提升 ReWalk 行業領先的全球聲譽。最終打造出一款針對實際使用進行最佳化的設備，提供無與倫比的用戶體驗和行動自由。我們非常高興能為全美癱瘓日常生活患者提供一種新的選擇，幫助他們將行走首席執行官——癱瘓日常生活患者——癱瘓日常生活患者提供一種新的選擇，幫助他們將行走首席執行官——他非常高興能為全美癱瘓日常生活患者提供一種新的選擇，幫助他們將行走首席執行官——他非常高興能融入日常生活患者——癱瘓日常生活患者的一種新的選擇，幫助他們將 Larrys 融入日常生活。

創傷性脊髓損傷（TRAS）發病率的上升正在推動美國外骨骼市場的成長。這是因為外骨骼被推薦用於緩解脊髓損傷患者的症狀。這是促使患者和醫療專業人員採用外骨骼的主要因素。例如，根據美國國家脊髓損傷統計中心（NSCISC）2024年的數據，創傷性脊髓損傷仍然是美國一個重要的公共衛生問題，根據最新估計，每年新增病例約18,400例。這一數字相當於每百萬人每年約有54例新診斷病例，凸顯了一般人群中持續存在的嚴重脊髓損傷風險。這些損傷的持續發生反映了人們持續暴露於交通事故、跌倒、運動傷害和職場等因素，導致需要長期復健、行動輔助和先進輔助技術的患者群體持續存在。

在建設業等體力勞動強度大的產業中，最常見的肌肉骨骼損傷和疾病包括職業過度使用症候群（OOS）、累積創傷障礙（CTD）和重複性勞損（RSI）。這些疾病是由重複性動作、搬運重物、不自然的姿勢以及工作中長時間過度勞累造成的。根據美國勞工統計局截至2023年8月的最新數據，2021年至2022年間，美國報告的職場肌肉骨骼疾病病例估計為502,380例，發病率約為每10,000名全職員工25.3例。這顯示這些損傷在美國各行各業普遍存在。

此外，根據WorkCare公司2025年3月發表的報導，更廣泛的估計表明，在美國，每年有超過一百萬起與工作相關的傷害是由肌肉骨骼疾病引起的，給雇主和員工都帶來了沉重的負擔。職業性肌肉骨骼疾病的高發生率是推動外骨骼解決方案日益普及的主要動力，因為這項技術有助於輔助和支持體力勞動，改善工人的健康狀況和生產力，並減輕產業工人的疲勞。

美國外骨骼市場的快速技術進步正在推動創新，並加速其在醫療、工業和消費領域的應用。例如，2026年1月，美國外骨骼領域的一項重大進展是在CES 2026等重要展會上發布了新型人工智慧驅動的穿戴式機器人系統。多家公司展示了新一代攜帶式外骨骼，這些外骨骼整合了即時人工智慧輔助功能，包括地形自適應控制，並採用緊湊、以用戶為中心的設計，支援用戶多樣化的移動方式，並減輕身體負擔。這些產品代表著外骨骼解決方案正朝著更智慧和適應性強的方向發展，旨在輔助完成從日常出行到高強度任務的各種工作，反映了美國可攜式機器人領域日益成長的興趣和商業性勢頭。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國外骨骼市場的影響因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
  • 市場動態
  • 外骨骼市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析
  • 美國外骨骼/外骨骼機器人市場的主要趨勢
  • 美國外骨骼/外骨骼機器人市場的主要發展動態
  • 美國外骨骼/外骨骼機器人市場專利分析
  • 案例研究與見解
  • 外骨骼供應鏈分析
  • 當前監管趨勢分析
  • 生態系分析
  • 價格分析
  • 未來市場創新

第4章：2021-2033年美國外骨骼市場按移動類型分類的銷售量（千台）

  • 定義和範圍
  • 依行程類型分類的市佔率分析（2025 年和 2033 年）
  • 美國外骨骼市場：依移動能力分類，2021-2033年
  • 美國外骨骼市場規模及預測：以移動方式分類，2021-2033年
  • 美國外骨骼市場規模及預測：依移動類型、銷售量分類，2021-2033 年（千台）
  • 手機類型
  • 固定式/獨立式

第5章：美國外骨骼市場細分分析（依技術分類，2021-2033 年，銷售量，單位：千台）

  • 定義和範圍
  • 按技術分類的市場佔有率分析（2025 年和 2033 年）
  • 美國外骨骼市場：依技術分類，2021-2033年
  • 美國外骨骼市場規模及預測：依技術分類，2021-2033年
  • 美國外骨骼市場規模及預測：依技術、銷售分類，2021-2033 年（千台）
  • 動力
  • 無動力

第6章：美國外骨骼市場區隔（依肢體分類），2021-2033年，銷售量（千台）

  • 定義和範圍
  • 按行業分類的市場佔有率分析（2025 年和 2033 年）
  • 美國外骨骼市場：依肢體分類，2021-2033 年
  • 美國外骨骼市場規模及預測：依肢體分類，2021-2033年
  • 美國外骨骼市場規模及預測（依肢體分類，銷售量，2021-2033 年，單位：千台）
  • 上半身
  • 下半身
  • 全身

第7章：美國外骨骼市場：依最終用途分類的估算與趨勢分析

    • 定義和範圍
  • 按最終用途分類的市場佔有率分析（2025 年和 2033 年）
  • 美國外骨骼市場：依應用領域分類，2021-2033年
  • 美國外骨骼市場規模及預測：依最終用途分類，2021-2033年
  • 美國外骨骼市場規模及預測：依最終用途及銷售分類，2021-2033 年（千台）
  • 醫療保健
    • 2021-2033年醫療保健市場估算與預測
  • 軍隊
    • 軍事市場估計與預測（2021-2033）
  • 產業
    • 2021-2033年工業市場估算與預測

第8章 競爭情勢

  • 近期趨勢及影響分析：依主要市場參與企業
  • 公司/競爭對手分類
  • 美國外骨骼/外骨骼機器人市場關鍵績效指標
  • 公司簡介
    • Ekso Bionics
    • Lockheed Martin Corporation
    • Suit X
    • Rex Bionics Plc.
    • ReWalk Robotics
    • DIH Medical
    • German Bionic
    • Sarcos Technology and Robotics Corporation
    • Parker Hannifin Corporation
    • Bionik Laboratories
Product Code: GVR-4-68040-858-0

U.S. Exoskeleton Market Summary

The U.S. exoskeleton market size was estimated at USD 234.18 million in 2025 and is projected to reach USD 640.25 million by 2033, growing at a CAGR of 13.09% from 2026 to 2033. The rapidly growing geriatric population, rising adoption of medical devices across industries such as automotive, military, defense, and construction, and the rising incidence of stroke are key drivers of growth in the U.S. exoskeleton industry.

The growing incidence rate of traumatic spinal cord injuries (SCI) is expected to drive the demand across U.S. markets. For instance, in September 2025, the United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls. It highlighted common secondary complications, including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.

Exoskeleton solutions are increasingly being adopted to support mobility restoration and rehabilitation, particularly for individuals with spinal cord injuries. In the U.S., ongoing innovation in wearable robotics is encouraging manufacturers to introduce next-generation systems with improved personalization and digital integration. For instance, in 2025, Lifeward Ltd. announced the nationwide U.S. commercialization of its latest personal exoskeleton, ReWalk 7. The new system incorporates advanced features such as cloud-based connectivity, adaptive software, and adjustable walking speeds, enabling a more tailored gait experience for users with spinal cord injuries. This launch reflects the company's strategic focus on enhancing user autonomy, clinical outcomes, and real-world usability of exoskeleton-assisted walking solutions in the U.S. market.

"The ReWalk 7 was developed over several years, integrating advanced technological innovations with feedback from clinicians and patients to build upon the ReWalk's world-class reputation for industry leadership, The result is a device that is optimized for real-world use, with an unmatched user experience and freedom of movement. We are thrilled to be able to provide paralyzed individuals across the country with a new option for integrating walking to everyday life." -Larry Jasinski, CEO of Lifeward

The increasing prevalence of traumatic spinal cord injury is boosting the growth of the U.S. exoskeleton market, as patients suffering from spinal cord injury are recommended to use an exoskeleton to improve their condition. This has become a key driver for the adoption of exoskeletons by patients and healthcare providers. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC) in 2024, in the U.S., traumatic spinal cord injury remains a significant public health concern, with recent estimates indicating that approximately 18,400 new cases are reported each year. This incident corresponds to around 54 newly diagnosed individuals per one million people annually, underscoring the persistent risk of severe spinal trauma across the population. The steady occurrence of these injuries reflects ongoing exposure to factors such as road traffic accidents, falls, sports-related injuries, and workplace incidents, contributing to a sustained patient pool requiring long-term rehabilitation, mobility assistance, and advanced supportive technologies.

Some of the most common musculoskeletal injuries and disorders affecting workers in physically demanding sectors such as construction include occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). These conditions arise from repetitive motions, heavy lifting, awkward postures, and prolonged exertion on the job. According to the most recent data from the U.S. Bureau of Labor Statistics in August 2023, an estimated 502,380 workplace musculoskeletal disorder cases were reported over the 2021-2022 period, with an incidence rate of about 25.3 cases per 10,000 full-time equivalent workers, illustrating the widespread nature of these injuries across U.S. industries.

In addition, as per the WorkCare, Inc. article published in March 2025, broader estimates suggest that musculoskeletal disorders account for over 1 million workplace injuries in the U.S. annually, placing a substantial burden on employers and workers alike. These high rates of work-related musculoskeletal issues are key drivers for the growing adoption of exoskeleton solutions, as such technology can help augment or support physical tasks, improve worker health and productivity, and reduce fatigue among industrial laborers.

Rapid technological advancements in the U.S. exoskeleton market are driving innovation, accelerating adoption across health care, industrial, and consumer segments. For instance, in January 2026, a key development in the U.S. is the recent unveiling of new AI-enabled wearable robotic systems at major trade events such as CES 2026, where several companies showcased next-generation portable exoskeletons that incorporate real-time AI-driven assistance, including terrain adaptive controls and compact, user-centric designs that support mobility and reduce physical exertion for diverse users. These products signal a shift toward more intelligent, adaptive exoskeleton solutions designed to assist both daily mobility and demanding tasks, reflecting growing interest and commercial momentum in the U.S. wearable robotics space.

U.S. Exoskeleton Market Report Segmentation

This report forecasts revenue and volume growth at the country level and provides an analysis of industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the U.S. exoskeleton market report based on mobility, technology, extremity, end-use, and region:

  • Mobility Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Mobile
  • Fixed/Stationary
  • Technology Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Powered
  • Non-powered
  • Extremity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Upper Body
  • Lower Body
  • Full Body
  • End-use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Healthcare
  • Military
  • Industry

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Mobility
    • 1.2.2. Technology
    • 1.2.3. Extremity
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Mobility outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Extremity outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Exoskeleton Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of spinal cord injury
      • 3.2.1.2. Increasing incidence of musculoskeletal disorders
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High procedural costs
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Exoskeleton Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Key Trends in the U.S. Exoskeleton/Exo Robots Market
  • 3.5. Key Developments in the U.S. Exoskeleton/Exo Robots Market
  • 3.6. Patent Analysis in the U.S. Exoskeleton/Exo Robots Market
  • 3.7. Case Studies & Insights
  • 3.8. Supply Chain Analysis for Exoskeletons
  • 3.9. Current Regulatory Analysis
  • 3.10. Ecosystem Analysis
  • 3.11. Pricing Analysis
  • 3.12. Upcoming Innovations in the Market

Chapter 4. U.S. Exoskeleton Market Segment Analysis, By Mobility 2021-2033 (USD Million), Unit Volume (000' Units)

  • 4.1. Definition and Scope
  • 4.2. Mobility Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. U.S. Exoskeleton Market, By Mobility, 2021 - 2033
  • 4.5. U.S. Exoskeleton Market Size & Forecasts, By Mobility, 2021 - 2033 (USD Million)
  • 4.6. U.S. Exoskeleton Market Size & Forecasts, By Mobility, Unit Volume, 2021 - 2033 (000' Units)
  • 4.7. Mobile
    • 4.7.1. Mobile market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 4.8. Fixed/Stationary
    • 4.8.1. Fixed/stationary market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 5. U.S. Exoskeleton Market Segment Analysis, By Technology 2021-2033 (USD Million), Unit Volume (000' Units)

  • 5.1. Definition and Scope
  • 5.2. Technology Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. U.S. Exoskeleton Market, By Technology, 2021 - 2033
  • 5.5. U.S. Exoskeleton Market Size & Forecasts, By Technology, 2021 - 2033 (USD Million)
  • 5.6. U.S. Exoskeleton Market Size & Forecasts, By Technology, Unit Volume, 2021 - 2033 (000' Units)
  • 5.7. Powered
    • 5.7.1. Powered market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
    • 5.7.2. Powered by Extremity
      • 5.7.2.1. Upper body
        • 5.7.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.7.2.2. Lower body
        • 5.7.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.7.2.3. Full body
        • 5.7.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 5.8. Non-Powered
    • 5.8.1. Non-powered market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
    • 5.8.2. Non-powered by Extremity
      • 5.8.2.1. Upper body
        • 5.8.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.8.2.2. Lower body
        • 5.8.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.8.2.3. Full body
        • 5.8.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 6. U.S. Exoskeleton Market Segment Analysis, By Extremity 2021-2033 (USD Million), Unit Volume (000' Units)

  • 6.1. Definition and Scope
  • 6.2. Extremity Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. U.S. Exoskeleton Market, By Extremity, 2021 - 2033
  • 6.5. U.S. Exoskeleton Market Size & Forecasts, By Extremity, 2021 - 2033 (USD Million)
  • 6.6. U.S. Exoskeleton Market Size & Forecasts, By Extremity, Unit Volume, 2021 - 2033 (000' Units)
  • 6.7. Upper Body
    • 6.7.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 6.8. Lower Body
    • 6.8.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 6.9. Full Body
    • 6.9.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 7. U.S. Exoskeleton Market: End Use Estimates & Trend Analysis

      • Definition and Scope
  • 7.1. End Use Market Share Analysis, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. U.S. Exoskeleton Market, By End Use, 2021 - 2033
  • 7.4. U.S. Exoskeleton Market Size & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.5. U.S. Exoskeleton Market Size & Forecasts, By End Use, Unit Volume, 2021 - 2033 (000' Units)
  • 7.6. Healthcare
    • 7.6.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 7.7. Military
    • 7.7.1. Military market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 7.8. Industry
    • 7.8.1. Industry market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. U.S. Exoskeleton/Exo Robots Key Market Performance Indicators
  • 8.4. Company Profiles
    • 8.4.1. Ekso Bionics
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Lockheed Martin Corporation
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Suit X
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Rex Bionics Plc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. ReWalk Robotics
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. DIH Medical
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. German Bionic
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Sarcos Technology and Robotics Corporation
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Parker Hannifin Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bionik Laboratories
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. exoskeleton market estimates and forecasts, by mobility, 2021 - 2033 (USD Million)
  • Table 4 U.S. exoskeleton market volume estimates and forecasts, by mobility, 2021 - 2033 (Volume, 000' Units)
  • Table 5 U.S. exoskeleton market estimates and forecasts, by technology, 2021 - 2033 (USD Million)
  • Table 6 U.S. exoskeleton market volume estimates and forecasts, by technology, 2021 - 2033 (Volume, 000' Units)
  • Table 7 U.S. exoskeleton market estimates and forecasts, by extremity, 2021 - 2033 (USD Million)
  • Table 8 U.S. exoskeleton market volume estimates and forecasts, by extremity, 2021 - 2033 (Volume, 000' Units)
  • Table 9 U.S. exoskeleton market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. exoskeleton market volume estimates and forecasts, by end use, 2021 - 2033 (Volume, 000' Units)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. exoskeleton market: market outlook
  • Fig. 7 U.S. exoskeleton competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 U.S. exoskeleton market driver impact
  • Fig. 11 U.S. exoskeleton market restraint impact
  • Fig. 12 U.S. exoskeleton market: Mobility movement analysis
  • Fig. 13 U.S. exoskeleton market: Mobility outlook and key takeaways
  • Fig. 14 Mobile market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 15 Fixed/stationary market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 16 U.S. exoskeleton market: Technology movement analysis
  • Fig. 17 U.S. exoskeleton market: Technology outlook and key takeaways
  • Fig. 18 Powered market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 19 Non-powered market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 20 U.S. exoskeleton market: Extremity movement analysis
  • Fig. 21 U.S. exoskeleton market: Extremity outlook and key takeaways
  • Fig. 22 Upper body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 23 Lower body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 24 Full body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 25 U.S. exoskeleton market: End Use movement analysis
  • Fig. 26 U.S. exoskeleton market: End Use outlook and key takeaways
  • Fig. 27 Healthcare market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 28 Military market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 29 Industry market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)